Has Kyle Stanley received payments from drug or device companies?

Yes. Drug and device makers reported $259,430 in general payments to Kyle Stanley across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Stanley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Stanley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Stanley

General Practice · Los Angeles, CANPI 1235427063

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $157,328 of the $259,430 with a category attached, or 60.6%. 11 manufacturers reported payments, led by Nobel Biocare USA at 36.8% of the total. Reporting peaked in 2023 at $69,045 and has fallen 53.2% since, to $32,300 in 2025. Among general practice clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$259,430in general payments, 2019–2025

Across 124 payments — averaging $2092.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nobel Biocare USA$96K
MIS Implants Technologies, Inc.$49K
Envista Holdings Corporation$42K
Dentsply Sirona Inc$33K
Straumann USA LLC$20K
Patterson Companies, Inc.$13K
plus $7K from 5 others

What the payments were for

Consulting fees$71,78828%
Speaking & faculty fees$157,32861%
Travel & lodging$15,2656%
Food & beverage$3,5191%
Education$2,0361%
Gifts$3000%
Entertainment$5000%
Charitable contribution$8,6943%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nobel Biocare USA	51	$95,590
MIS Implants Technologies, Inc.	16	$48,637
Envista Holdings Corporation	8	$41,964
Dentsply Sirona Inc	24	$33,489
Straumann USA LLC	10	$20,169
Patterson Companies, Inc.	5	$12,845
Geistlich Pharma, North America, Inc.	3	$3,312
Sprintray Inc	3	$1,548
GC America Inc.	1	$1,000
Sirona Dental, Inc.	2	$750
Ortho Organizers, Inc.	1	$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$259,430 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.

See all general practice providers in California →

Other general practice in Los Angeles

Abdi SameniLos Angeles$316K
Kent HwangLos Angeles$290K
Richard KimLos Angeles$97K
Michael SchneiderLos Angeles$53K
Ronald JeffersonLos Angeles$45K
Nathan LiLancaster$5.2M
Milton McCollSan Jose$4.9M
Frederic MollRedwood City$2.5M
Bradley ChingUpland$1.4M
Eric BrassTorrance$755K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →